Literature DB >> 9884484

Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan.

C J Chang1, Y C Ko, H W Liu.   

Abstract

The purpose of this study was to determine the risk factors for hepatitis C virus (HCV) infection among drug abusers in southern Taiwan. This survey included 935 drug abusers from Kaohsiung Narcotic Abstention Institute and Kaohsiung prison. The prevalence of anti-HCV antibody was 29.1% among male drug abusers and 19.4% among female drug abusers. The seroprevalence of anti-HCV antibody was 66.4% among intravenous drug abusers and 14.4% among nonintravenous drug abusers. Intravenous drug use, a history of hepatitis, having tattoos, and age were independently related to HCV seropositivity among drug abusers. The prevalence of anti-HCV antibody concentrations significantly increased (10.8-fold) with intravenous drug abuse and with having tattoos (1.7-fold). These findings suggest that hepatitis C virus is mainly transmitted by the parenteral route among drug abusers in southern Taiwan. Due to the high rate of HCV infection among drug abusers, investigation of high-risk behavior should be routine in this group. To prevent HCV infection, emphasis on the use of sterile needles and aseptic procedures in tattooing is important in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884484

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Tattoos: a photo essay.

Authors:  M H Christensen
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

2.  Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

Authors:  Sérgio A de Nishioka; T W Gyorkos; L Joseph; J P Collet; J D MacLean
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.

Authors:  Meng-Hsuan Hsieh; Jih-Jin Tsai; Ming-Yen Hsieh; Chung-Feng Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ko Chang; Wei-Ru Lin; Chun-Yu Lin; Tun-Chieh Chen; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.